Helixgate

Helixgate

Uncategorized

The next era of diabetes management

The next era of diabetes management

Published

on

In this episode of Denatured, you’ll be hearing from Dr. Sarah Howell, CEO at Arecor Therapeutics and Dr. Wendy S. Lane, clinical endocrinologist and diabetologist. We examine how increasingly connected and tailored diabetes technologies are reframing the field’s central opportunity around minimizing the day-to-day demands of managing the condition.​ ​Read More

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

GSK cuts deal with Sino to broaden reach of hepatitis B drug

The marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and could speed access to a therapy called bepirovirsen that’s important to its future.

Read More

Published

on

The marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and could speed access to a therapy called bepirovirsen that’s important to its future.

Read More

Continue Reading

Uncategorized

Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise push

Published

on

Daiichi Sankyo is betting on its oncology franchise to push it past 3 trillion Japanese yen ($19 billion) in 2030 revenues.

The drugmaker published a new five-year business plan on Monday …

Continue Reading

Uncategorized

New home for Novo’s Parkinson’s cell therapy; GSK turns to China for hep B drug

Published

on

Plus, label expansions for two drugs targeting rare diseases, and Genmab scraps a Phase 1 cancer trial:

🧠 Novo’s Parkinson’s cell therapy finds a biotech home: Novo Nordisk has found a home for an early-stage …

Continue Reading
Advertisement

Trending